Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough

Alpha-Synuclein as a Biomarker of Parkinson’s Disease: Good, but Not Good Enough

Parkinson’s disease (PD) is the second most common neurodegenerative disorder of the elderly, presenting primarily with symptoms of motor impairment. The disease is diagnosed most commonly by clinical examination with a great degree of accuracy in specialized centers. However, in some cases, non-cla...

Full description

Bibliographic Details
Main Authors: Upasana Ganguly, Sukhpal Singh, Soumya Pal, Suvarna Prasad, Bimal K. Agrawal, Reena V. Saini, Sasanka Chakrabarti
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Aging Neuroscience
Subjects:
imaging biomarkers
cerebrospinal fluid
α-synuclein oligomers
phosphorylated α-synuclein
extracellular vesicles
metabolomics
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.702639/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2021.702639/full

Similar Items